Acme United(US:ACU)2026-02-26 15:27Financial Performance - Net sales for Q4 2025 were $47.5 million, a 3% increase from $45.9 million in Q4 2024[1] - Net income for Q4 2025 was $1.9 million, or $0.46 per diluted share, representing a 10% increase in net income and a 12% increase in diluted earnings per share compared to Q4 2024[2] - U.S. segment net sales were constant in Q4 2025 compared to Q4 2024, but declined 1% for the full year[4] - European net sales increased 31% in U.S. dollars and 22% in local currency for Q4 2025, with an 8% increase in net sales for the full year[5] - Canadian net sales increased 14% in both U.S. dollars and local currency for Q4 2025, with the same percentage increase for the full year[6] - Gross margin for Q4 2025 was 38.2%, down from 38.7% in Q4 2024, while the full year gross margin was 39.4%, slightly up from 39.3%[7] Acquisition and Expansion - The company acquired My Medic in January 2026 for $18.7 million, with 2025 revenues of approximately $19 million, aiming to expand its product offerings and distribution[3] Debt and Cash Flow - The company's bank debt less cash decreased to $18.1 million as of December 31, 2025, from $21.5 million a year earlier[8] - The company generated approximately $13.6 million in free cash flow before the purchase of a new $6 million manufacturing facility in Tennessee[9] Assets - Total assets increased to $170.998 million as of December 31, 2025, compared to $162.170 million a year earlier[21]